
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Investment firm which in backing biotech, offering investors the opportunity to back promising medical innovations via the EIS and SEIS.
Investor Profile
O2h Ventures has made 34 investments, with 3 in the past 12 months and 32% as lead.
Stage Focus
- Seed (47%)
- Series Unknown (15%)
- Series A (9%)
- Pre Seed (9%)
- Series C (6%)
- Series B (6%)
- Equity Crowdfunding (3%)
- Convertible Note (3%)
- Grant (3%)
Country Focus
- United Kingdom (94%)
- Hungary (6%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Medical
- Pharmaceutical
- Artificial Intelligence (Ai)
- Life Science
- Saas
- Software
- Delivery
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.